Transcriptional Profiling of Endocrine Cerebro-Osteodysplasia Using Microarray and Next-Generation Sequencing
2011

Gene Expression Profiling in ECO Syndrome

Sample size: 3 publication 10 minutes Evidence: moderate

Author Information

Author(s): Lahiry Piya, Lee Leo J., Frey Brendan J., Rupar C. Anthony, Siu Victoria M., Blencowe Benjamin J., Hegele Robert A.

Primary Institution: Robarts Research Institute, London, Ontario, Canada

Hypothesis

How do gene expression patterns differ in fibroblasts from patients with ECO syndrome compared to unaffected individuals?

Conclusion

mRNA-seq is more sensitive and accurate than microarray for identifying differentially expressed genes in ECO syndrome.

Supporting Evidence

  • mRNA-seq identified more differentially expressed genes than microarrays.
  • Correlation with qRT-PCR was better for mRNA-seq than for microarrays.
  • Both platforms showed high numbers of differentially expressed genes in ECO-affected fibroblasts.

Takeaway

Scientists looked at the genes in skin cells from kids with a rare disease and found that a special test showed more differences than an older test.

Methodology

The study used cDNA microarrays and next-generation mRNA sequencing to profile gene expression in skin fibroblasts from ECO patients and controls.

Potential Biases

There may be biases in gene expression results due to the reliance on specific technologies.

Limitations

The study was limited by the small sample size and the potential for false negatives in microarray data.

Participant Demographics

The study included two ECO-affected individuals and one unaffected control from the Amish community.

Statistical Information

P-Value

P<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0025400

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication